KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Asset Utilization Ratio (2016 - 2025)

Edwards Lifesciences (EW) has 16 years of Asset Utilization Ratio data on record, last reported at 0.45 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 7.65% year-over-year to 0.45; the TTM value through Dec 2025 reached 0.45, up 7.65%, while the annual FY2025 figure was 0.45, 6.52% down from the prior year.
  • Asset Utilization Ratio reached 0.45 in Q4 2025 per EW's latest filing, up from 0.44 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.66 in Q2 2021 and bottomed at 0.42 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.53, with a median of 0.53 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: dropped 27.74% in 2023, then rose 9.12% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.63 in 2021, then fell by 16.04% to 0.53 in 2022, then rose by 1.43% to 0.53 in 2023, then decreased by 21.85% to 0.42 in 2024, then increased by 7.65% to 0.45 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.45 in Q4 2025, 0.44 in Q3 2025, and 0.43 in Q2 2025.